SCHEMBL6651622

SCHEMBL6651622

CN1CCCCC1CO.Cc1[nH]c2ccc(OC(C)C3CCCCN3)cc2c1C(=O)OCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
CHRNB2 P17787 1/20 0.39
CHRNA5 P30532 1/20 0.39
CHRNA7 P36544 1/20 0.39
CHRNA4 P43681 1/20 0.39
MAPKAPK2 P49137 1/20 0.37
SLC6A3 Q01959 7/20 0.37
SLC6A2 P23975 5/20 0.37
SLC6A4 P31645 3/20 0.37
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
ALDH1A1 P00352 2/20 0.36
ALOX15 P16050 2/20 0.36
KCNH2 Q12809 1/20 0.36
MCHR1 Q99705 1/20 0.36
DHFR P00374 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6314852 0.90 GAA (0.42) GAAMAPKAPK2SLC6A3SLC6A2SLC6A4
SCHEMBL6651618 0.85 KCNH2 (0.49) KDM4EGAACHRNB2CHRNA5CHRNA7
SCHEMBL6314845 0.82 CHRNB2 (0.52) KDM4EGAACHRNB2CHRNA5CHRNA7
SCHEMBL6316849 0.76 LMNA (0.46) KDM4EGAAMAPKAPK2CHRM2CHRM4
SCHEMBL6316646 0.75 GAA (0.41) KDM4EGAAMAPKAPK2CHRM2CHRM4
SCHEMBL6323679 0.75 GAA (0.44) KDM4EGAAMAPKAPK2CHRM2CHRM4
SCHEMBL6323062 0.74 SPHK1 (0.44) KDM4EGAAALDH1A1ALOX15MCHR1
SCHEMBL6323053 0.74 SPHK1 (0.44) KDM4EGAAALDH1A1ALOX15MCHR1
SCHEMBL6316727 0.72 LTA4H (0.48) KDM4EGAAALDH1A1LMNA
SCHEMBL6316855 0.72 HTT (0.53) KDM4EALDH1A1KCNH2MCHR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1377549-A1 FUNCTIONALIZED HETEROCYCLES AS MODULATORS OF CHEMOKINE RECEPTOR FUNCTION AND METHODS OF USE THEREFOR Millennium Pharmaceuticals, Inc. (US) 2004-01-07 EP disclosed
WO-2002072549-A1 FUNCTIONALIZED HETEROCYCLES AS MODULATORS OF CHEMOKINE RECEPTOR FUNCTION AND METHODS OF USE THEREFOR MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-09-19 WO disclosed